CSIMarket
 


Alaunos Therapeutics Inc   (TCRT)
Other Ticker:  
 

Alaunos Therapeutics Inc 's Total Debt to Equity

TCRT's quarterly Total Debt to Equity and Total Debt, Equity growth




TCRT Total Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -53.26 % -54.49 % -53.5 % -59.94 % -57.96 %
Y / Y Total Debt Change -6.37 % - - - -
Total Debt to Equity MRQ 0.71 0.61 0.5 0.42 0.35
Overall Ranking # 1768 # 0 # 0 # 0 # 0
Seq. Equity Change -20.08 % -18.2 % -15.39 % -15.5 % -22.17 %
Seq. Total Debt Change -7.56 % 0.85 % 0.82 % -0.38 % -



Total Debt to Equity third quarter 2022 Comment
In Spite of the debt repayement of -7.56%, in III. Quarter ,Total Debt to Equity detoriated to 0.71, a new company high.

Within Major Pharmaceutical Preparations industry in the third quarter 2022, 118 other companies have achieved lower Total Debt to Equity than Alaunos Therapeutics Inc . While Total Debt to Equity total ranking has deteriorated compare to the previous quarter from 0 to 1768.

Explain Debt to Equity Ratio?
Where is TCRT most successful ?
Total Debt to Equity TCRT on the trailing twelve month basis
Total Debt to Equity third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 119
Healthcare Sector # 312
Overall Market # 1768


Total Debt to Equity Statistics
High Average Low
0.71 0.52 0.35
(Sep 30 2022)   (Sep 30 2021)




Financial Statements
Alaunos Therapeutics Inc 's Equity $ 32 Millions Visit TCRT's Balance sheet
Alaunos Therapeutics Inc 's Total Debt $ 23 Millions Visit TCRT's Balance sheet
Source of TCRT's Sales Visit TCRT's Sales by Geography


Cumulative Alaunos Therapeutics Inc 's Total Debt to Equity

TCRT's Total Debt to Equity for the trailling 12 Months

TCRT Total Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -53.26 % -54.49 % -53.5 % -59.94 % -57.96 %
Y / Y Total Debt TTM Growth -6.37 % - - - -
Total Debt to Equity TTM 0.53 0.45 0.27 0.15 0.06
Total Ranking TTM # 1749 # 1839 # 1677 # 1266 # 0
Seq. Equity TTM Growth -20.08 % -18.2 % -15.39 % -15.5 % -22.17 %
Seq. Total Debt TTM Growth -7.56 % 0.85 % 0.82 % -0.38 % -


TTM Total Debt to Equity Comment
On the trailing twelve months basis Despite of the debt repayement of -7.56% in III. Quarter, Total Debt to Equity improved to 0.53, above Alaunos Therapeutics Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 116 other companies have achieved lower Total Debt to Equity than Alaunos Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. 1749.

Explain Debt to Equity Ratio?
Where is TCRT most successful ?
Total Debt to Equity TCRT on the trailing twelve month basis

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 117
Healthcare Sector # 320
Within the Market # 1749


TTM Total Debt to Equity Statistics
High Average Low
0.36 0.17 0.03
(Sep 30 2022)   (Sep 30 2021)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2022 MRQ Total DebtSep 30 2022 MRQ Equity
Phibro Animal Health Corporation  1.78 $ 467.158  Millions$ 262.756  Millions
G1 Therapeutics Inc   1.67 $ 76.558  Millions$ 45.965  Millions
Mallinckrodt Plc  1.66 $ 3,078.400  Millions$ 1,849.100  Millions
China Pharma Holdings Inc   1.60 $ 4.550  Millions$ 2.835  Millions
Eli Lilly And Company  1.56 $ 15,888.400  Millions$ 10,165.900  Millions
Zoetis Inc   1.41 $ 6,563.000  Millions$ 4,662.000  Millions
9 Meters Biopharma Inc   1.37 $ 18.390  Millions$ 13.461  Millions
Aveo Pharmaceuticals Inc   1.34 $ 38.678  Millions$ 28.845  Millions
Bristol myers Squibb Company  1.19 $ 39,098.000  Millions$ 32,734.000  Millions
Ocular Therapeutix Inc   1.15 $ 53.344  Millions$ 46.229  Millions
Chembio Diagnostics Inc   1.07 $ 18.994  Millions$ 17.793  Millions
Viatris Inc   1.04 $ 19,988.700  Millions$ 19,182.300  Millions
Landec Corporation  1.02 $ 98.569  Millions$ 96.899  Millions
Pacira Biosciences inc   0.97 $ 747.871  Millions$ 770.123  Millions
Neptune Wellness Solutions Inc   0.94 $ 14.692  Millions$ 15.596  Millions
Ani Pharmaceuticals inc  0.92 $ 286.732  Millions$ 311.825  Millions
Evoke Pharma Inc   0.90 $ 5.000  Millions$ 5.533  Millions
Fortress Biotech Inc   0.90 $ 91.165  Millions$ 101.352  Millions
Catalent Inc   0.89 $ 4,204.000  Millions$ 4,700.000  Millions
Prestige Consumer Healthcare Inc   0.89 $ 1,438.338  Millions$ 1,619.841  Millions
Elanco Animal Health Inc  0.87 $ 5,901.000  Millions$ 6,745.000  Millions
Rockwell Medical inc   0.87 $ 14.093  Millions$ 16.136  Millions
Marinus Pharmaceuticals Inc   0.86 $ 70.780  Millions$ 82.004  Millions
Innoviva Inc   0.84 $ 539.810  Millions$ 641.368  Millions
Spectrum Pharmaceuticals Inc   0.79 $ 28.488  Millions$ 35.852  Millions
Avid Bioservices Inc   0.77 $ 140.097  Millions$ 181.195  Millions
Journey Medical Corporation  0.76 $ 19.810  Millions$ 26.184  Millions
Otonomy Inc   0.75 $ 16.130  Millions$ 21.397  Millions
Seres Therapeutics Inc   0.75 $ 50.857  Millions$ 67.585  Millions
Cryoport inc   0.73 $ 407.432  Millions$ 555.721  Millions

Date modified: 2022-11-16T22:21:07+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APOG's Profile

Stock Price

APOG's Financials

Business Description

Fundamentals

Charts & Quotes

APOG's News

Suppliers

APOG's Competitors

Customers & Markets

Economic Indicators

APOG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071